Travis Revelle named Chief Executive Officer of Healthcare Solutions Holdings, Inc. Jonathan Globerman named Chief Operating Officer of Healthcare Solutions Holdings, Inc.
Travis Revelle named Chief Executive Officer of Healthcare Solutions Holdings, Inc. Jonathan Globerman named Chief Operating Officer of Healthcare Solutions Holdings, Inc.
NEW YORK, April 3, 2019 /PRNewswire/ -- Healthcare Solutions announced today that Travis Revelle has been appointed the Chief Executive Officer for Healthcare Solutions Holdings, Inc., “HSI.” Mr. Revelle’s career has spanned a large segment of the healthcare services industry, with a focus on sales and distribution for new and innovative diagnostic products. Under Mr. Revelle’s leadership and in coordination with the HSI platform, we believe that the company is uniquely positioned to capitalize in today’s healthcare market – by assisting physicians to deliver superior patient outcomes and cost savings through the integration of the latest medical technologies directly into their practices.
HSI’s board of directors has also appointed Jonathan Globerman as Chief Operating Officer. Jonathan has a strong belief that HSI can solve problems and improve efficiencies for its customers through the integration of new technology. Jonathan states, “I commonly hear from our provider customers that they had difficulty getting the combination of service level, science and benefit utilization for their patients from the ancillary service providers that they had access to. HSI combats this challenge by providing a ‘service first’ offering which allows our physician customers to have single points of service contact across multiple ancillary product lines. This creates efficiencies within the office, resulting in better access to best-in-class products for providers.”
HSI is a service business with core strengths in the following areas:
Laboratory
HSI has recently expanded the company’s laboratory test offerings to include laboratories specializing in Toxicology, Clinical Blood Wellness, Pharmacogenetics, Infectious Diseases, Cancer Genetics and more. We believe that our advanced technology contribution creates the most efficient ordering, results in the process, and also allows for efficient integrations with our customers EHR/EMR systems.
Durable Medical Equipment
HSI’s DME offering is a customizable and full-service program that can accommodate a broad range of customers including stock and bill programs or full-service fulfillment from prescriptions received through the billing of claims. This allows us to provide our customers with a customizable and proprietary level of service that is required in an ever-demanding market place.
Specialty Pharmacy
HSI’s specialty pharmacy offering creates a patient-focused experience that is unparalleled from today’s “big box” providers. Delivering medications directly to the patient’s home, along with exceptional contract coverage and a service team that is available to patients and focused on their needs this, creates the mom and pop atmosphere with corporate level execution.
HSI has strong underpinnings:
HSI’s Core Pillars
The underlying core pillars of HSI are customer service, technology, and finance.
Customer Service: Physicians will be given one point of contact across multiple service offerings, creating efficiencies and conveniences at the customer level. Our service will allow them to focus on what’s most important, which is their patients.
Technology: HSI delivers state of the art technology and modern systems. This enables our physician customers to spend more time treating patients to render the best outcome possible.
Finance: HSI has assets in excess of $80 million dollars, provided from a sizeable international capital markets consortium. These assets are critical in HSI’s roll-up strategy and compliance application. Our strategic utilization of these assets will help us capitalize on opportunities to provide outstanding services for our customers and outcomes for our shareholders.
Technology
At HSI, we will work as a technology aggregator with the world’s leading innovators, developers, and inventors. Our growth strategy includes utilizing our equity to roll up these advanced technologies. We have initiated early conversations with companies and products that can be profoundly impactful in the global healthcare community.
Finance
We have focused on utilizing our financial capacity to build our internal infrastructure and customer base. This has equated to our team onboarding 84 new accounts since the start of the year and the subsequent transition into the revenue cycle on many of them. With our customer footprint expanding, HSI has been aggressively recruiting and expanding its operations and support team.
About Healthcare Solutions Holdings, Inc.
HSI is a medical service, and device company focused on providing clinicians with state-of-the-art diagnostic and therapeutic tools. Our mission is to improve patient outcomes by helping clinicians gain broader access to the most advanced technology in the healthcare industry. HSI does not only focus on assisting physicians with exceptional healthcare delivery, but also promoting compliance with the industry’s best practices.
Healthcare Solutions, Inc., headquartered in Glen Cove, New York. Please visit www.hscorp.biz for additional information.
Forward-Looking Statements: This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,” “future,” “plan” or “planned,” “will” or “should,” “expected,” “anticipates,” “draft,” “eventually” or “projected.”
You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in the Company’s Annual Report on Form 10-K for the fiscal year ended Dec. 31, 2014, and other filings made by the Company with the U.S. Securities and Exchange Commission.
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as “will,” “commitment,” “continue,” “pipeline,” or similar expressions, or by express or implied discussions regarding potential future sales or earnings of HSI. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those outlined in the forward-looking statements. There can be no guarantee that HSI will be commercially successful in the future, or achieve any particular financial results. In particular, our expectations could be affected by, among other things: regulatory actions or delays or government regulation generally; the potential that the strategic benefits, synergies or opportunities expected from the significant acquisitions, divestments and reorganizations of recent years may not be realized or may take longer to realize than expected; the uncertainties inherent in the research and development of new healthcare products; our ability to obtain or maintain proprietary intellectual property protection on key products; safety, quality or manufacturing issues; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures; uncertainties regarding actual or potential legal proceedings; and other risks. HSI is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
CONTACT INFORMATION
Healthcare Solutions Holdings, Inc.
For Investor Relations Phone: +1 (866) 668-2188;
Corporate Email:
HSI Media Relations – mr@hscorp.biz
HSI Investor Relations – ir@hscorp.biz
3 School St
Suite 303
Glen Cove, NY 11542
Related Files
Related Images
healthcare-solutions-holdings-inc.jpg
Related Links
Healthcare Solutions Holdings, Inc. - Website
View original content to download multimedia:http://www.prnewswire.com/news-releases/healthcare-solutions-inc-announces-key-executive-appointments-300824346.html
SOURCE Healthcare Solutions Holdings, Inc.
